Corpus callosum damage predicts disability progression and cognitive dysfunction in primary-progressive MS after five years

Human Brain Mapping

Volumn 34, Issue 5, 2013, Pages 1163-1172

  Bodini, Benedetta ^a   Cercignani, Mara ^a,b   Khaleeli, Zhaleh ^a   Miller, David H ^a   Ron, Maria ^a   Penny, Sophie ^a   Thompson, Alan J ^a   Ciccarelli, Olga ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Lesion filling; Neuropsychological assessment; Primary progressive multiple sclerosis; Tract based spatial statistics; Voxel based morphometry

Indexed keywords

ADULT; ARTICLE; ATTENTION; BRAIN SIZE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; EXECUTIVE FUNCTION; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; FRACTIONAL ANISOTROPY; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS; PRIORITY JOURNAL; VERBAL MEMORY; VOXEL BASED MORPHOMETRY;

ADULT; ANISOTROPY; BRAIN MAPPING; COGNITION DISORDERS; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; DISABILITY EVALUATION; DISABLED PERSONS; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL RECALL; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES;

EID: 84875900854     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.21499     Document Type: Article

References (55)

1. Abe O, Masutani Y, Aoki S, Yamasue H, Yamada H, Kasai K, Mori H, Hayashi N, Masumoto T, Ohtomo K ( 2004): Topography of the human corpus callosum using diffusion tensor tractography. J Comput Assist Tomogr 28: 533-539.
2. Andersen RA, Buneo CA ( 2002): Intentional maps in posterior parietal cortex. Annu Rev Neurosci 25: 189-220.
3. Ashburner J, Friston KJ ( 2000): Voxel-based morphometry-The methods. Neuroimage 11: 805-821.
4. Ashburner J, Friston KJ ( 2005): Unified segmentation. Neuroimage 26: 839-851.
5. Bakshi R, Thompson AJ, Rocca MA, Pelletier D, Dousset V, Barkhof F, Inglese M, Guttmann CR, Horsfield MA, Filippi M ( 2008): MRI in multiple sclerosis: Current status and future prospects. Lancet Neurol 7: 615-625.
6. Basser PJ, Mattiello J, LeBihan D ( 1994): Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 103: 247-254.
7. Bodini B, Khaleeli Z, Cercignani M, Miller DH, Thompson AJ, Ciccarelli O ( 2009): Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: An in vivo study with TBSS and VBM. Hum Brain Mapp 30: 2852-2861.
8. Bogen JE, Fisher ED, Vogel PJ ( 1965): Cerebral commissurotomy. A second case report. JAMA 194: 1328-1329.
9. Buchsbaum BR, Greer S, Chang WL, Berman KF ( 2005): Meta-analysis of neuroimaging studies of the Wisconsin card-sorting task and component processes. Hum Brain Mapp 25: 35-45.
10. Buckner RL, Wheeler ME ( 2001): The cognitive neuroscience of remembering. Nat Rev Neurosci 2: 624-634.
11. Burgess PW, Shallice T ( 1997): The Hayling and Brixton Tests. Bury St. Edmunds: Thames Valley Test Company.
12. Ceccarelli A, Rocca MA, Pagani E, Colombo B, Martinelli V, Comi G, Filippi M ( 2008): A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage 42: 315-322.
13. Chao YP, Cho KH, Yeh CH, Chou KH, Chen JH, Lin CP ( 2009): Probabilistic topography of human corpus callosum using cytoarchitectural parcellation and high angular resolution diffusion imaging tractography. Hum Brain Mapp 30: 3172-3187.
14. Chard DT, Jackson JS, Miller DH, Wheeler-Kingshott CA ( 2010): Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 32: 223-228.
15. Coombs BD, Best A, Brown MS, Miller DE, Corboy J, Baier M, Simon JH ( 2004): Multiple sclerosis pathology in the normal and abnormal appearing white matter of the corpus callosum by diffusion tensor imaging. Mult Scler 10: 392-397.
16. Cottrell DA, Kremenchutzky M, Rice GP, Koopman WJ, Hader W, Baskerville J, Ebers GC ( 1999): The natural history of multiple sclerosis: A geographically based study. V. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122 ( Part 4): 625-639.
17. Coughlan AK, Hollows AK ( 1985): The Adult Memory and Information Processing Battery. Leeds: St James's University Hospital, AK Coughlan.
18. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E ( 1999): Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122 ( Part 5): 871-882.
19. De Stefano N, Giorgio A, Battaglini M, Rovaris M, Sormani MP, Barkhof F, Korteweg T, Enzinger C, Fazekas F, Calabrese M, Dinacci D, Tedeschi G, Gass A, Montalban X, Rovira A, Thompson A, Comi G, Miller DH, Filippi M ( 2010): Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology 74: 1868-1876.
20. Dineen RA, Vilisaar J, Hlinka J, Bradshaw CM, Morgan PS, Constantinescu CS, Auer DP ( 2009): Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132: 239-249.
21. Dziedzic T, Metz I, Dallenga T, Konig FB, Muller S, Stadelmann C, Bruck W ( 2010): Wallerian degeneration: A major component of early axonal pathology in multiple sclerosis. Brain Pathol 20: 976-985.
22. Fisher E, Lee JC, Nakamura K, Rudick RA ( 2008): Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol 64: 255-265.
23. Garrard P, Bradshaw D, Jäger HR, Thompson AJ, Losseff N, Playford D ( 2002): Cognitive dysfunction after isolated brain stem insult. An underdiagnosed cause of long term morbidity. J Neurol Neurosurg Psychiatry 73: 191-194.
24. Gazzaniga MS ( 2005): Forty-five years of split-brain research and still going strong. Nat Rev Neurosci 6: 653-659.
25. Geurts JJ, Kooi EJ, Witte ME, van der Valk P ( 2010): Multiple sclerosis as an "inside-out" disease. Ann Neurol 68: 767-768.
26. He Y, Dagher A, Chen Z, Charil A, Zijdenbos A, Worsley K, Evans A ( 2009): Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load. Brain 132: 3366-3379.
27. Jasperse B, Vrenken H, Sanz-Arigita E, de G, V, Smith SM, Polman CH, Barkhof F ( 2007): Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis. Neuroimage 38: 529-537.
28. Jokinen H, Ryberg C, Kalska H, Ylikoski R, Rostrup E, Stegmann MB, Waldemar G, Madureira S, Ferro JM, van Straaten EC, Scheltens P, Barkhof F, Fazekas F, Schmidt R, Carlucci G, Pantoni L, Inzitari D, Erkinjuntti T ( 2007): Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: The LADIS Study. J Neurol Neurosurg Psychiatry 78: 491-496.
29. Kern KC, Sarcona J, Montag M, Giesser BS, Sicotte NL ( 2010): Corpus callosal diffusivity predicts motor impairment in relapsing-remitting multiple sclerosis: A TBSS and tractography study. Neuroimage 55: 1169-1177.
30. Khaleeli Z, Cercignani M, Audoin B, Ciccarelli O, Miller DH, Thompson AJ ( 2007): Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 37: 253-261.
31. Kurtzke JF ( 1983): Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33: 1444-1452.
32. Langdon DW ( 2011): Cognition in multiple sclerosis. Curr Opin Neurol 24: 244-249.
33. Mesaros S, Rocca MA, Riccitelli G, Pagani E, Rovaris M, Caputo D, Ghezzi A, Capra R, Bertolotto A, Comi G, Filippi M ( 2009): Corpus callosum damage and cognitive dysfunction in benign MS. Hum Brain Mapp 30: 2656-2666.
34. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ ( 2002): Measurement of atrophy in multiple sclerosis: Pathological basis, methodological aspects and clinical relevance. Brain 125: 1676-1695.
35. Mori S, Wakana S, Nagae-Poetscher LM, van Zijl PC ( 2005): MRI Atlas of Human White Matter. Elsevier: Amsterdam, The Netherlands.
36. Nakamura K, Fisher E ( 2009): Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients. Neuroimage 44: 769-776.
37. Nelson HE ( 1982): The National Adult Reading Test, Windsor: NFER-Nelson.
38. Ozturk A, Smith SA, Gordon-Lipkin EM, Harrison DM, Shiee N, Pham DL, Caffo BS, Calabresi PA, Reich DS ( 2010): MRI of the corpus callosum in multiple sclerosis: Association with disability. Mult Scler 16: 166-177.
39. Park HJ, Kim JJ, Lee SK, Seok JH, Chun J, Kim DI, Lee JD ( 2008): Corpus callosal connection mapping using cortical gray matter parcellation and DT-MRI. Hum Brain Mapp 29: 503-516.
40. Penny S, Khaleeli Z, Cipolotti L, Thompson A, Ron M ( 2010): Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis. Neurology 74: 545-552.
41. Plummer D ( 1992): DispImage: A display and analysis tool for medical images. Rev Neuroradiol 5: 489-495.
42. Roosendaal SD, Geurts JJ, Vrenken H, Hulst HE, Cover KS, Castelijns JA, Pouwels PJ, Barkhof F ( 2009): Regional DTI differences in multiple sclerosis patients. Neuroimage 44: 1397-1403.
43. Rosenfeld and Kak ( 1982): Digital Picture Processing 2, Academic Press: Orlando, FL, p. 42.
44. Rugg MD, Otten LJ, Henson RN ( 2002): The neural basis of episodic memory: Evidence from functional neuroimaging. Philos Trans R Soc Lond B Biol Sci 357: 1097-1110.
45. Sdika M, Pelletier D ( 2009): Nonrigid registration of multiple sclerosis brain images using lesion inpainting for morphometry or lesion mapping. Hum Brain Mapp 30: 1060-1067.
46. Smith A ( 1982): Symbol Digit Modalities Test (SDMT) Manual (revised). Los Angeles: Western Psychological Services.
47. Smith SM, Nichols TE ( 2009): Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44: 83-98.
48. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De LM, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De SN, Brady JM, Matthews PM ( 2004): Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 ( Suppl 1): S208-S219.
49. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE ( 2006): Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 31: 1487-1505.
50. Srikanth V, Phan TG, Chen J, Beare R, Stapleton JM, Reutens DC ( 2010): The location of white matter lesions and gait-A voxel-based study. Ann Neurol 67: 265-269.
51. Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH, Polman CH, Stevenson VL, McDonald WI ( 2000): Diagnostic criteria for primary progressive multiple sclerosis: A position paper. Ann Neurol 47: 831-835.
52. Tremlett H, Paty D, Devonshire V ( 2005): The natural history of primary progressive MS in British Columbia, Canada. Neurology 65: 1919-1923.
53. Voineskos AN, Rajji TK, Lobaugh NJ, Miranda D, Shenton ME, Kennedy JL, Pollock BG, Mulsant BH ( 2010): Age-related decline in white matter tract integrity and cognitive performance: A DTI tractography and structural equation modeling study. Neurobiol Aging [Epub ahead of print].
54. Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC ( 1991): The natural history of multiple sclerosis: A geographically based study. IV. Applications to planning and interpretation of clinical therapeutic trials. Brain 114 ( Part 2): 1057-1067.
55. Wingerchuk DM, Noseworthy JH, Weinshenker BG ( 1997): Clinical outcome measures and rating scales in multiple sclerosis trials. Mayo Clin Proc 72: 1070-1079.